Beijing Centergate Technologies (holding) Co., Ltd. (SHE:000931)

China flag China · Delayed Price · Currency is CNY
4.150
-0.100 (-2.35%)
Jul 13, 2026, 3:04 PM CST
Market Cap3.20B -21.0%
Revenue (ttm)2.30B -9.6%
Net Income15.87M -72.5%
EPS0.02 -72.5%
Shares Out 753.13M
PE Ratio201.49
Forward PEn/a
Dividend0.02 (0.47%)
Ex-Dividend DateJun 12, 2026
Volume9,474,142
Open4.210
Previous Close4.250
Day's Range4.090 - 4.250
52-Week Range3.910 - 5.860
Beta0.33
Analystsn/a
Price Targetn/a
Earnings DateAug 22, 2026

About SHE:000931

Beijing Centergate Technologies (holding) Co., Ltd. engages in the production and sale of topical reagents, tablets, injections in China. The company offers Anemarrhena saponin BII and capsules for vascular dementia treatment; Naltrexone Hydrochloride tablets and injections to block the pharmacological effects of exogenous opioids; Acetaminophen and oxycodone tablets and injections for the treatment of moderate to severe pain; tramadol hydrochloride tablets and injections to treat pain in adults; aprolol hydrochloride for the treatment of hyper... [Read more]

Sector Healthcare
Founded 1999
Employees 2,267
Stock Exchange Shenzhen Stock Exchange
Ticker Symbol 000931
Full Company Profile

Financial Performance

In 2025, SHE:000931's revenue was 2.44 billion, a decrease of -3.52% compared to the previous year's 2.53 billion. Earnings were 47.89 million, a decrease of -10.65%.

Financial Statements